Multiple Companies Report Q3FY26 Results for Quarter Ended December 2025
Several Indian companies published Q3FY26 financial results for quarter ended December 31, 2025, showing mixed performance across sectors. Healthcare leader Krishna Institute of Medical Sciences reported strong revenue growth of 23.93% to ₹4,562 million, while agrochemical company Best Agrolife faced revenue decline to ₹128.61 crore with continued losses.

*this image is generated using AI for illustrative purposes only.
Several Indian companies have published their quarterly financial results for the third quarter of fiscal year 2026, covering the period ended December 31, 2025. The results were announced in compliance with Regulation 33 and 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Healthcare and Pharmaceutical Sector Performance
Krishna Institute of Medical Sciences Limited reported strong performance with total income reaching ₹4,562 million for the quarter, compared to ₹3,681 million in the corresponding quarter of the previous year. The healthcare provider's net profit after tax stood at ₹725 million for the quarter ended December 31, 2025.
| Parameter: | Q3 FY26 | Q3 FY25 | Change |
|---|---|---|---|
| Total Income (₹ million): | 4,562 | 3,681 | +23.93% |
| Net Profit After Tax (₹ million): | 725 | 765 | -5.23% |
| Earnings Per Share (₹): | 1.81 | 1.91 | -5.24% |
Brooks Laboratories Limited posted total income from operations of ₹1,669.13 lakh for the quarter, showing a decline from ₹2,054.30 lakh in the same quarter last year. The pharmaceutical company's net profit after tax was ₹30.28 lakh compared to ₹93.65 lakh in the previous year quarter.
Agrochemical and Chemical Industries
Best Agrolife Limited reported total income from operations of ₹128.61 crore for the quarter ended December 31, 2025, compared to ₹193.27 crore in the corresponding quarter of the previous year. The agrochemical company recorded a net loss after tax of ₹5.76 crore for the quarter, compared to a loss of ₹6.08 crore in the same period last year.
| Financial Metric: | Q3 FY26 | Q3 FY25 | Nine Months FY26 |
|---|---|---|---|
| Total Income (₹ crore): | 128.61 | 193.27 | 807.26 |
| Net Loss After Tax (₹ crore): | (5.76) | (6.08) | 52.11 |
| Earnings Per Share (₹): | (0.16) | (0.17) | 1.47 |
Pee Cee Cosma Sope Limited demonstrated robust growth with total income from operations reaching ₹4,238.28 lakh for the quarter, significantly higher than ₹3,451.30 lakh in the corresponding quarter of the previous year. The company's net profit after tax improved to ₹304.51 lakh from ₹294.38 lakh year-over-year.
Regulatory Compliance and Corporate Actions
Several companies also announced regulatory compliance measures and corporate actions. Pasupati Acrylon Limited issued a notice regarding SEBI's special window for transfer and dematerialization of physical shares, available from February 5, 2026, to February 4, 2027. Devyani International Limited announced the dispatch of postal ballot notices for special resolutions including re-classification of authorized share capital and issuance of non-convertible redeemable preference shares.
| Company: | Key Development |
|---|---|
| Pasupati Acrylon: | Special window for physical share transfers |
| Devyani International: | Postal ballot for capital restructuring |
| Shriram Finance: | Branch relocation notice |
The quarterly results reflect varied performance across different sectors, with healthcare companies showing resilience while some agrochemical firms faced challenges. All companies have complied with regulatory requirements for timely disclosure of financial results and maintained transparency in their reporting processes.

































